Skip to content Skip to menu

Medicines Australia welcomes more money in the PBS

Thursday, 3 May 2018

Media Release

Medicines Australia welcomes the announcement from the Minister for Health, the Hon Greg Hunt MP’s that there will be additional funding for the PBS.

Speaking at the Australian Pharmacy Professional Conference (APP2018) this morning, Minister Hunt flagged changes that would ultimately allow for more new medicines to be listed on the PBS earlier and would improve access to the latest in innovative medicines for all Australians.

Minister Hunt has flagged that there will be ‘a very significant provision’ available to fund vital new medicines, following Tuesday’s Budget, and has reinforced the Coalition’s commitment to list all new medicines recommended by the PBAC.

Medicines Australia, who represent the innovative medicines manufacturers in Australia, has consistently communicated to the Minister the need to improve PBS funding; to list new medicines through timely and efficient processes; and to ensure that Australian patients can have access to the new medicines they need, when they need them. We welcome his statements that indicate the Government’s ongoing commitment to the industry.

We note the Government’s intention to change the payment arrangements through the supply chain to resolve pharmacy cash-flow concerns. We will continue to work constructively to ensure that Australian medicines manufacturers are well prepared for the changes that will have an impact on them.

Medicines Australia looks forward to the release of more details in the next week’s Federal Budget.

MA also welcomes the Government’s commitment to ensuring value for money and transparency in all expenditure of the PBS.



Natalie Wimmer – 0450 728 660



As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at